FY2019 Requests for Applications

These Funding Opportunity Announcements (FOA) are associated with the Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, these FOAs target the following area designated as scientific priority by the Blue Ribbon Panel (BRP):
Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers.

  • RFA-CA-19-012, Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3 Clinical Trials Not Allowed)
  • RFA-CA-19-013, Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed)
  • RFA-CA-19-014, Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)
  • RFA-CA-19-015, Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)

The FY2019 requests for applications have been closed. The earliest start date for the IOTN FY19 awardee will be September 2019, and the detailed information of awardees will be available at IOTN awardees.